Medical Devices Startups

Kidney-Chek offers an at-home, saliva-based test for pet owners to screen companion animals such as cats for kidney disease, severe dehydration, and other health issues. The clinically validated test aims to enable early detection and proactive veterinary care.

1 investor

KIJI Tx develops gene-engineered iPSC-derived MSC cell therapies for treating a broad range of inflammatory diseases, with a lead product using IL10 and CXCR4 transduction. The company works in collaboration with research institutions including CIBER, Fundación Jiménez Díaz, and CIEMAT.

1 investor

Kilele Health develops biosensing medical devices for patient monitoring and diagnostics. The company combines advanced biosensing technology with expertise in medtech development and commercialization to serve healthcare providers and patients.

1 investor

Kilobaser develops tabletop DNA and RNA synthesizers designed for laboratory professionals to produce custom oligonucleotides on demand. The company targets life science researchers and lab professionals seeking independent access to genetic material synthesis.

1 investor

Kinetikos Health develops digital health technology that measures human movement with laboratory-grade precision, converting motion data into standardized biomechanical parameters for use in clinical research and professional healthcare settings.

1 investor

KinetiTec develops an in-bed exercise system for hospitalized patients to maintain mobility and muscle strength during their hospital stay. The system combines resistance movement, cardiopulmonary engagement, and AI-driven risk detection for nurses and physical therapists in acute care settings.

1 investor

Kinex Medical is an orthopedic specialty medical equipment company that delivers durable medical equipment and orthotics for post-acute and in-home rehabilitation. The company handles product fitting, billing, collections, and payer coordination while monitoring patient progress and offering telehealth rehabilitation products.

1 investor

Kiniksa is a global biopharmaceutical company that discovers and develops novel therapies for patients with unmet medical needs, with a focus on cardiovascular diseases and related conditions. The company has an FDA-approved therapy and multiple clinical-stage assets in its pipeline.

1 investor

Kinnos makes Highlight, a colorant additive for disinfectant wipes that provides real-time visual feedback on surface coverage and cleaning technique to healthcare facilities. The technology helps staff and facilities improve disinfection effectiveness and consistency without changing existing cleaning workflows.

1 investor

Kinomica develops mass spectrometry-based diagnostic tests that measure protein activity to predict patient responses to multiple drugs. The company aims to advance precision medicine by enabling companion diagnostics that help match patients to appropriate therapeutic options.

1 investor

Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.

1 investor

Kintsugi Therapeutics is a preclinical-stage biopharmaceutical company developing first-in-class endoplasmic reticulum stress inhibitors for treating non-alcoholic steatohepatitis and other liver conditions.

1 investor

Klarismo provides cloud-based software that converts full-body MRI scans into interactive 3D virtual models of the body, with automated analysis of body composition including muscle and fat tissue measurements. The platform uses machine learning to analyze large volumes of scans simultaneously without manual processing.

1 investor

Klinrisk develops prognostic AI-driven tests for cardiovascular, renal, and metabolic conditions using routine lab data to identify high-risk patients earlier in their disease progression. The company serves patients, healthcare providers, and health systems with products that integrate into existing clinical workflows for disease risk stratification and prevention.

1 investor

KLISBio develops a silk fibroin-based biointegrative platform for nerve repair and other medical applications. The company serves medtech markets focused on biocompatible medical devices and biomaterials.

1 investor

Kmina manufactures and sells powered wheelchairs designed for mobility assistance, offering foldable models with lithium-ion batteries and safety features for users with mobility needs.

1 investor

Kneevoice develops a non-invasive cartilage auscultation device that captures knee joint sounds, vibrations, and position data to assess cartilage damage for use by medical providers and physical therapists. The system processes this data through a proprietary algorithm to generate a damage score, helping clinicians and patients make informed treatment decisions.

1 investor

Known Medicine develops a predictive engine using AI and patient datasets to identify optimal cancer treatments for individual patients. The company serves oncologists and cancer patients through computational analysis of biomaterials and drug-discovery data.

1 investor

KOKO Medical is a development-stage medical device startup building a catheter-based device that encourages uterine contractions and removes excess blood to treat postpartum hemorrhage. Its technology targets maternal health, aiming to help mothers experiencing heavy bleeding after childbirth.

1 investor

KoKo develops spirometers and pulmonary function testing (PFT) devices and software for respiratory diagnostics, serving healthcare providers globally. The company manufactures high-accuracy medical equipment and information systems for respiratory care.

1 investor

KolateAI provides AI-driven software solutions to optimize the drug development process, including clinical trials and real-world studies. The platform serves pharmaceutical companies and research organizations seeking to improve efficiency and accelerate drug development timelines.

1 investor

Kompass Diagnostics is developing a rapid point-of-care hormone testing platform that uses a cartridge-based analyzer to quantify hormone levels quickly and store results in EHR systems. Its tests target fertility, reproductive, and thyroid monitoring for clinics, satellite locations, Ob/Gyn providers, and diagnostic centers.

1 investor

Koning Health develops cone beam CT imaging technology for breast cancer detection and diagnosis. The company serves medical imaging facilities and healthcare providers focused on early detection and biopsy of breast cancer.

1 investor

Korio provides RTSM (Randomization and Trial Supply Management) software for clinical trials, with a focus on experienced project management and continuity throughout the study lifecycle. The company serves clinical operations teams and sponsors managing treatment assignment and supply logistics in regulated pharmaceutical trials.

1 investor